Updated Jul 2, 2007 at 23:9 EST.
Plethora Solutions Holding PLC continues to push forward with its spray treatment for premature ejaculation ( PE ), PSD502. The company plans to introduce the drug on the market by 2009. The approval process continues for the drug and results look positive.
The drug has not yet obtained final approval since it has to undergo final stage clinical trials. Those trials are expected to be completed within the next 15 months. The company already markets an injectable treatment for erectile dysfunction and hopes to expand its reach into the male and female sexual health market with PSD502.
Written by the PEhomepage.com Editorial Team.
Back to Articles 
Latest News Archive 
E-mail a Friend
